CAPRELSA (AstraZeneca Pharmaceuticals LP)
Welcome to the PulseAid listing for the CAPRELSA drug offered from AstraZeneca Pharmaceuticals LP. This Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AstraZeneca Pharmaceuticals LP |
| NON-PROPRIETARY NAME: | Vandetanib |
| SUBSTANCE NAME: | VANDETANIB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-07-25 |
| END MARKETING DATE: | 0000-00-00 |
CAPRELSA HUMAN PRESCRIPTION DRUG Details:
| Item Description | CAPRELSA from AstraZeneca Pharmaceuticals LP |
| LABELER NAME: | AstraZeneca Pharmaceuticals LP |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/1) |
| START MARKETING DATE: | 2011-07-25 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0310-7820_93695e2a-3d45-452d-aa6e-1e14181e56fa |
| PRODUCT NDC: | 0310-7820 |
| APPLICATION NUMBER: | NDA022405 |
Other VANDETANIB Pharmaceutical Manufacturers / Labelers:
